| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $515.7M | +19.9% |
| Cost of Revenue | $236.0M | +12.8% |
| Gross Profit | $279.6M | +26.7% |
| R&D Expense | $66.1M | +30.5% |
| SG&A Expense | $64.4M | +26.8% |
| Operating Income | -$77.9M | -6.2% |
| Pre-tax Income | -$78.8M | -5.9% |
| Income Tax | $1.2M | -62.4% |
| Net Income | -$80.0M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $533.9M | +205.0% |
| Accounts Receivable | $73.2M | +58.2% |
| Current Assets | $641.9M | +170.9% |
| Total Assets | $739.9M | +162.3% |
| Current Liabilities | $341.3M | +29.4% |
| Total Liabilities | $350.2M | +30.3% |
| Stockholders' Equity | $389.7M | +249.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | -173.8% |
| Capital Expenditures | $5.3M | +3.0% |
| Investing Cash Flow | -$52.7M | -262.5% |
| Financing Cash Flow | $418.6M | +219.3% |
| Free Cash Flow | -$12.4M | -379.9% |
| -3.1% |
| EPS (Basic) | -$1.46 | +37.3% |
| EPS (Diluted) | -$1.46 | +37.3% |